Compare ORGO & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORGO | AIRS |
|---|---|---|
| Founded | 1985 | 2012 |
| Country | United States | United States |
| Employees | 854 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.6M | 182.4M |
| IPO Year | 2016 | 2021 |
| Metric | ORGO | AIRS |
|---|---|---|
| Price | $1.04 | $1.24 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 3 |
| Target Price | $2.00 | ★ $4.50 |
| AVG Volume (30 Days) | 750.4K | ★ 826.2K |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1600.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $564,169,000.00 | $151,818,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $37.55 | $2.65 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 17.04 | N/A |
| 52 Week Low | $0.93 | $1.16 |
| 52 Week High | $7.08 | $12.00 |
| Indicator | ORGO | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 26.19 | 24.50 |
| Support Level | N/A | N/A |
| Resistance Level | $2.57 | $3.31 |
| Average True Range (ATR) | 0.08 | 0.13 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 22.22 | 8.57 |
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.